HC Wainwright Analysts Decrease Earnings Estimates for OpGen
HC Wainwright Analysts Decrease Earnings Estimates for OpGen, Inc. (NASDAQ:OPGN)
OpGen, Inc. (NASDAQ:OPGN – Free Report) – Investment analysts at HC Wainwright decreased their Q3 2023 earnings per share (EPS) estimates for shares of OpGen in a report issued on Monday, August 14th. HC Wainwright analyst Y. Chen now expects that the medical research company will post earnings per share of ($0.43) for the quarter, […]
Related Keywords
United States, , Nasdaq, Virtu Financial, Citadel Advisors, Gene Panel, Dimensional Fund Advisors, Vanguard Group Inc, Opgen Inc, Opgen Company Profile, Free Report, Gen Stock Down, Get Free Report, Fund Advisors, Opgen Daily, Opgen, Nasdaq Opgn, Opgn, Medical, Earnings Estimates, Hc Wainwright,